1. Home
  2. ADM vs WAT Comparison

ADM vs WAT Comparison

Compare ADM & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Archer-Daniels-Midland Company

ADM

Archer-Daniels-Midland Company

HOLD

Current Price

$57.59

Market Cap

30.4B

ML Signal

HOLD

Logo Waters Corporation

WAT

Waters Corporation

HOLD

Current Price

$383.80

Market Cap

22.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADM
WAT
Founded
1902
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Staples
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
30.4B
22.5B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
ADM
WAT
Price
$57.59
$383.80
Analyst Decision
Hold
Buy
Analyst Count
6
15
Target Price
$55.67
$390.67
AVG Volume (30 Days)
2.7M
586.9K
Earning Date
02-03-2026
02-11-2026
Dividend Yield
3.55%
N/A
EPS Growth
N/A
3.82
EPS
2.46
10.88
Revenue
$83,211,000,000.00
$3,105,638,000.00
Revenue This Year
N/A
$7.96
Revenue Next Year
$4.44
$6.32
P/E Ratio
$23.35
$35.23
Revenue Growth
N/A
6.90
52 Week Low
$40.98
$275.05
52 Week High
$65.00
$423.56

Technical Indicators

Market Signals
Indicator
ADM
WAT
Relative Strength Index (RSI) 41.22 50.58
Support Level $57.89 $372.17
Resistance Level $60.59 $385.69
Average True Range (ATR) 1.27 8.82
MACD -0.14 -2.82
Stochastic Oscillator 11.11 39.34

Price Performance

Historical Comparison
ADM
WAT

About ADM Archer-Daniels-Midland Company

Archer-Daniels-Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. The company is also one of the largest grain merchandisers through its extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients and is a large producer of corn-based sweeteners, starches, and ethanol.

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

Share on Social Networks: